The Barriers to Insulin Therapy Initiation in Type 2 Diabetes Patients: A Study of General Practitioner Perceptions in Huinan Community in South Shanghai
Song Wen,Yufeng Ruan,Zhongyu Shi,Shujie Dan,Ligang Zhou
DOI: https://doi.org/10.2147/dmso.s446349
2024-01-24
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Song Wen, 1, &ast Yufeng Ruan, 2, &ast Zhongyu Shi, 3 Shujie Dan, 2 Ligang Zhou 1– 4 1 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China; 2 Department of General Practice, Huinan Health Service Center, Shanghai, People's Republic of China; 3 Department of International Medicine, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China; 4 Shanghai Key Laboratory of Vascular Lesions Regulation and Remodeling, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ligang Zhou, Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, 201399, People's Republic of China, Tel +8613611927616, Email Background: Despite the demonstrated benefits of insulin therapy, many general practitioners (GPs) are hesitant to administer it due to challenges such as a lack of knowledge, time constraints, and patient reluctance. The barriers that prevent a GP from initiating insulin therapy may vary in comparison to those encountered by a diabetic patient; this aspect of clinical research in the South Shanghai metropolitan area has received limited attention so far. Objective: This is a 6-months of interventional analytic cohort study. The prime aim is to investigate the barriers general practitioners (GPs) face when initiating insulin therapy for patients with type 2 diabetes (T2D). Materials and Methods: As part of a training program, all 189 registered GPs in Nanhui Health Service Center in Shanghai were given a structured online-multi-choice questionnaire before and after a six-month interval, during which the GPs received sessions of training on insulin therapy either on theoretic classes or clinical practices. Results: Before and after training, via the methods of multiple-response analyses, the results showed that social, GP's, and patient barriers to initiating insulin therapy were comparable. However, through the crosstabs chi-square test, we found significant changes in the basal insulin initiation following the prescription of the senior endocrinologists, the titration of insulin, and the need for training (p< 0.05). The Spearman analyses discovered significant changes associated with the cause of initial insulin refusal and the factors influencing insulin administration. Finally, the binary logistic regression analysis revealed that distinct causes such as social factors, insurance, GP experience, insulin dosage calculation, follow-up, and patients' feelings are related to insulin treatment application before and after training. Conclusion: According to this study, training increased general practitioners' confidence in initiating insulin administration, especially basal insulin. General practitioners require additional education on insulin therapy, with a potential need for increased face-to-face training for insulin initiation. Keywords: diabetes mellitus, insulin initiation barrier, general practitioner, community The chronic disease Type 2 Diabetes (T2D) affects millions of individuals worldwide. It is characterized by increased blood glucose levels caused by inadequate insulin production 1 or utilization. 2 Insulin is a hormone that regulates glucose levels in the blood, and its absence or resistance can result in severe diseases such as cardiovascular disease, renal failure, and blindness. 3 Insulin therapy is necessary for the effective control of diabetes, but its acceptability by general practitioners (GPs) is limited by a variety of barriers. 4,5 Insulin therapy initiation is challenging for various parties, including the patient, the physician, the family, the social worker, and the nurse. 6,7 The patient's fear of injections is a significant obstacle to using insulin in primary care. 8 Nevertheless, GPs were presented with additional challenges to insulin therapy. Some GPs may lack the confidence to initiate insulin therapy and the knowledge and skills necessary to manage insulin therapy effectively. 9 In addition, general practitioners may be concerned about patient compliance, 10 the occurrence of severe hypoglycemia, 11 and a lack of time to educate patients on insulin administration. 12 To overcome these challenges, GPs must have adequate knowledge and training in insulin management. 13,14 This may include lectures, workshops, and other training programs emphasizing the safe and effective administration of insulin to diabetic patients.<s -Abstract Truncated-
endocrinology & metabolism